CRH Medical Corp (TSE:CRH) – Equities research analysts at Beacon Securities issued their FY2019 earnings estimates for shares of CRH Medical in a note issued to investors on Monday, March 18th. Beacon Securities analyst D. Cooper expects that the company will post earnings of $0.49 per share for the year. Beacon Securities also issued estimates for CRH Medical’s FY2020 earnings at $0.49 EPS.
Other equities research analysts have also recently issued reports about the company. Acumen Capital lowered their target price on CRH Medical from C$6.25 to C$6.00 in a research note on Friday, March 15th. TD Securities lowered their target price on CRH Medical from C$6.50 to C$5.50 and set a “buy” rating on the stock in a research note on Wednesday, January 9th.
CRH Medical (TSE:CRH) last issued its quarterly earnings data on Wednesday, March 13th. The company reported C$0.03 earnings per share for the quarter, meeting the consensus estimate of C$0.03. The company had revenue of C$42.33 million for the quarter, compared to the consensus estimate of C$41.45 million.
About CRH Medical
CRH Medical Corporation provides various products and services to gastroenterologists for the treatment of gastrointestinal diseases in the United States, Canada, and internationally. It offers CRH O'Regan system, a single use, disposable, and hemorrhoid banding technology for treating various grades of hemorrhoid.
Recommended Story: What is a recession?
Receive News & Ratings for CRH Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CRH Medical and related companies with MarketBeat.com's FREE daily email newsletter.